Clinical Cancer Research Research Funding
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Clinical Cancer Research 14, 14-24, January 1, 2008. doi: 10.1158/1078-0432.CCR-07-1033
© 2008 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bird, B. R.J. H.
Right arrow Articles by Swain, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bird, B. R.J. H.
Right arrow Articles by Swain, S. M.
Related Collections
Right arrow Therapeutics and Targets
Right arrow Therapeutics and Targets: Pharmacology and Toxicology

Reviews

Cardiac Toxicity in Breast Cancer Survivors: Review of Potential Cardiac Problems

Brian R.J. Healey Bird1 and Sandra M. Swain2

Authors' Affiliations: 1 Breast Cancer Section, Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health and 2 Washington Cancer Institute, Washington Hospital Center, Washington, District of Columbia

Requests for reprints: Sandra M. Swain, Washington Cancer Institute, Washington Hospital Center, 110 Irving Street NW, Washington, DC 20010. Phone: 202-877-8112; Fax: 202-877-8113; E-mail: Sandra.M.Swain{at}Medstar.net.

As breast cancer survival is increased by the diagnosis of earlier-stage disease and treatments improve, the side effects of cancer treatments, such as cardiotoxicity, remain clinically important. Although physicians have known for 30 years that anthracyclines cause acute and chronic cardiotoxicity, the cardiotoxic effects of radiation therapy, hormonal therapy (including tamoxifen and the aromatase inhibitors), and chemotherapy with taxanes and trastuzumab treatment have emerged more recently. This review examines the cardiac toxicity of adjuvant therapy, monitoring for early changes and existing guidelines for monitoring cardiac function in patients with breast cancer.




This article has been cited by other articles:


Home page
CirculationHome page
M. H. Chen, R. Kerkela, and T. Force
Mechanisms of Cardiac Dysfunction Associated With Tyrosine Kinase Inhibitor Cancer Therapeutics
Circulation, July 1, 2008; 118(1): 84 - 95.
[Full Text] [PDF]


Home page
CRO ContentHome page
G. C. Prendergast
Cancer Management Hatches New Research Problems
Cancer Reviews Online Content, February 1, 2008; 2008(2): 3 - 3.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2008 by the American Association for Cancer Research.